TRIB NASDAQ
Trinity Biotech plc
1W: -15.8%
1M: -40.7%
3M: +1301.5%
YTD: +662.5%
1Y: +457.8%
3Y: -68.0%
5Y: -89.6%
$5.69
-0.63 (-9.97%)
Weekly Expected Move ±7.9%
$5
$5
$6
$6
$7
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$4M
+63.7% ▲
Capital Expenditures
$10M
-1153.3% ▼
5Y CAGR: -8.1%
Free Cash Flow
-$14M
-15.3% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$1M
+151.1% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$6M | $875K | -$41M | -$24M | -$32M |
| Depreciation & Amort. | $3M | $3M | $2M | $2M | $2M |
| Stock-Based Comp. | $792K | $1M | $2M | $2M | $1M |
| Change in Working Capital | $4M | -$172K | -$2M | -$3M | $6M |
| Other Non-Cash Items | $22M | $9M | $38M | $11M | $18M |
| Operating Cash Flow | $24M | $13M | -$921K | -$12M | -$4M |
| — Investing Activities — | |||||
| Capital Expenditures | -$10M | -$9M | -$6M | -$803K | -$405K |
| Acquisitions (Net) | $0 | $0 | $0 | $28M | -$13M |
| Investment Purchases | $0 | $0 | $0 | -$700K | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $0 | $0 | $0 | -$2M | -$10M |
| Investing Cash Flow | -$10M | -$9M | -$6M | $25M | -$23M |
| — Financing Activities — | |||||
| Net Debt Issuance | -$3M | -$3M | -$27M | -$7M | $28M |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $524K | -$3M | -$11M | -$9M | -$6M |
| Financing Cash Flow | -$3M | -$6M | -$12M | -$16M | $29M |
| Net Change in Cash | $11M | -$1M | -$19M | -$3M | $1M |
| Cash End of Period | $27M | $26M | $7M | $4M | $5M |
| Free Cash Flow | $14M | $5M | -$7M | -$12M | -$14M |